NCT06961968View on ClinicalTrials.gov

Randomized Withdrawal Study in Patients With Schizophrenia

PHASE3RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Schizophrenia
Interventions
DRUG

iloperidone

iloperidone LAI

DRUG

placebo

matching placebo

Trial Locations (2)

75080

RECRUITING

Vanda Investigational Site, Richardson

92102

RECRUITING

Vanda Investigational Site, San Diego

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY